Compumedics Limited (CMP.AX)
AUD 0.26
(0.0%)
AUD 0.26
(0.0%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 2 Million | 48.99 Thousand | 3.28 Million | 1.32 Million | 5.38 Million | 5.13 Million |
| Net Income | -338 Thousand | -6.12 Million | 1.35 Million | 998 Thousand | -5.83 Million | 4.01 Million |
| Depreciation & Amortization | 1.57 Million | 1.01 Million | 1.21 Million | 1.45 Million | 1.66 Million | 331 Thousand |
| Deferred income taxes | - | - | - | -41 Thousand | -1.77 Million | 1.14 Million |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | 1.54 Million | 1.78 Million | 231 Thousand | -1.04 Million | 3.32 Million | 234 Thousand |
| Other non-cash items | -780 Thousand | 3.37 Million | 487 Thousand | 2.58 Million | 9.54 Million | 789 Thousand |
| Investing Cash Flow | -2.98 Million | -4.4 Million | -2.98 Million | -1.55 Million | -4.23 Million | -4.28 Million |
| Investments in PPE | -2.98 Million | -4.4 Million | -2.98 Million | -1.55 Million | -4.23 Million | -1.31 Million |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | -2.67 Million | -3.48 Million | -2.36 Million | -1.39 Million | -3.82 Million | -2.97 Million |
| Financing Cash Flow | -1.49 Million | -1 Million | 1.61 Million | -179 Thousand | 448 Thousand | 149 Thousand |
| Debt repayment | -946 Thousand | -415 Thousand | -2.28 Million | -739 Thousand | -1.49 Million | -732 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -544 Thousand | -589.99 Thousand | 3.89 Million | 560 Thousand | 1.94 Million | 881 Thousand |
| Accounts receivables | 3.82 Million | 1.51 Million | -987 Thousand | -415 Thousand | 3.38 Million | 471 Thousand |
| Accounts payables | 1.37 Million | 385 Thousand | 555 Thousand | 1.55 Million | -554 Thousand | -701 Thousand |
| Inventory | -2.52 Million | -981 Thousand | -30 Thousand | -847 Thousand | -1.03 Million | -237 Thousand |
| Other working capital | 250 Thousand | 870 Thousand | 693 Thousand | -1.34 Million | 1.52 Million | 701 Thousand |
| Cash at beginning of period | 2.3 Million | 7.29 Million | 6.77 Million | 6.41 Million | 4.59 Million | 3.2 Million |
| Cash at end of period | -269 Thousand | 3.79 Million | 7.29 Million | 6.77 Million | 6.41 Million | 4.37 Million |
| Capital Expenditure | -2.98 Million | -4.4 Million | -2.98 Million | -1.55 Million | -4.23 Million | -1.31 Million |
| Effect of forex changes on cash | -93 Thousand | 370 Thousand | 236 Thousand | -465 Thousand | 46 Thousand | 172 Thousand |
| Net cash flow / Change in cash | -2.56 Million | -3.49 Million | 524 Thousand | 358 Thousand | 1.81 Million | 1.17 Million |
| Free Cash Flow | -986 Thousand | -4.35 Million | 302 Thousand | -230 Thousand | 1.15 Million | 3.82 Million |
| Breakdown | 2024 FY | 2024 Q4 | 2024 Q2 | 2023 Q4 | 2023 FY | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -499 Thousand | -479 Thousand | 141 Thousand | 1.09 Million | -6.12 Million | -7.21 Million |
| Depreciation & Amortization | 1.49 Million | 713 Thousand | 857 Thousand | 547 Thousand | 1.01 Million | 3.55 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | 2.46 Million | 1.54 Million | - | 1.21 Million | 1.78 Million | - |
| Other non-cash items | -149 Thousand | -956 Thousand | 1.89 Million | 423 Thousand | 3.37 Million | 9.84 Million |
| Investing Cash Flow | -4.22 Million | -2.04 Million | -947 Thousand | -2.18 Million | -4.4 Million | -2.21 Million |
| Investments in PPE | -4.22 Million | -92 Thousand | -947 Thousand | -2.18 Million | -4.4 Million | -2.21 Million |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | -1.94 Million | -726 Thousand | -1.78 Million | -3.48 Million | -1.7 Million |
| Financing Cash Flow | -1.49 Million | -654 Thousand | -836 Thousand | -757 Thousand | -1 Million | -248 Thousand |
| Debt repayment | -946 Thousand | -502 Thousand | -444 Thousand | -483 Thousand | -415 Thousand | -68 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | - | -654 Thousand | -392 Thousand | -757 Thousand | -589.99 Thousand | -248 Thousand |
| Accounts receivables | 3.89 Million | 3.82 Million | - | 1.51 Million | 1.51 Million | - |
| Accounts payables | 1.37 Million | - | - | - | 385 Thousand | - |
| Inventory | -2.22 Million | -2.52 Million | - | -981 Thousand | -981 Thousand | - |
| Other working capital | -587 Thousand | 250 Thousand | - | 683 Thousand | 870 Thousand | - |
| Cash at beginning of period | 3.79 Million | 1.49 Million | 3.79 Million | 5.66 Million | 7.29 Million | 7.29 Million |
| Cash at end of period | 1.88 Million | 1.88 Million | 3.67 Million | 3.79 Million | 3.79 Million | 5.66 Million |
| Capital Expenditure | -4.22 Million | -92 Thousand | -947 Thousand | -2.18 Million | -4.4 Million | -2.21 Million |
| Effect of forex changes on cash | - | 108 Thousand | -201 Thousand | 218 Thousand | 370 Thousand | 152 Thousand |
| Net cash flow / Change in cash | -1.91 Million | 395 Thousand | -127 Thousand | -1.87 Million | -3.49 Million | -1.62 Million |
| Free Cash Flow | -847 Thousand | 735 Thousand | 227 Thousand | -1.22 Million | -4.35 Million | -3.13 Million |
603926
603773
APETF
SBYSF
PIFYF
GTII